Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
292 studies found for:    Open Studies | "Pharyngeal Diseases"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Pharyngeal Diseases" (292 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Not yet recruiting The Danish General Rural Population Study
Conditions: Impaired Health;   Disease;   Wellbeing;   Mental Disorders;   Atherosclerosis;   Renal Insufficiency, Chronic;   Skin Diseases;   Urinary Incontinence;   Personality;   Coronary Disease;   Ear Diseases;   Nose Diseases;   Pharyngeal Diseases;   Chronic Disease
Intervention:
2 Not yet recruiting ACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing Definitive Treatment
Conditions: Oral Cavity Neoplasm;   Oropharyngeal Neoplasm;   Stage I Oral Cavity Squamous Cell Carcinoma;   Stage I Oropharyngeal Squamous Cell Carcinoma;   Stage II Oral Cavity Squamous Cell Carcinoma;   Stage II Oropharyngeal Squamous Cell Carcinoma;   Stage III Oral Cavity Squamous Cell Carcinoma;   Stage III Oropharyngeal Squamous Cell Carcinoma;   Stage IVA Oral Cavity Squamous Cell Carcinoma;   Stage IVA Oropharyngeal Squamous Cell Carcinoma;   Stage IVB Oral Cavity Squamous Cell Carcinoma;   Stage IVB Oropharyngeal Squamous Cell Carcinoma;   Stage IVC Oral Cavity Squamous Cell Carcinoma;   Stage IVC Oropharyngeal Squamous Cell Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Metformide Hydrochloride/Pioglitazone Hydrochloride Extended-Release Tablet;   Other: Pharmacological Study;   Other: Placebo
3 Recruiting EpCAM CAR-T for Treatment of Nasopharyngeal Carcinoma and Breast Cancer
Conditions: Malignant Neoplasm of Nasopharynx TNM Staging Distant Metastasis (M);   Breast Cancer Recurrent
Intervention: Biological: CAR-T cells recognizing EpCAM
4 Not yet recruiting The Study to Evaluate JS001 in Patients With Advanced GC, ESCC, NPC, HNSCC
Conditions: Gastric Adenocarcinoma;   Esophageal Squamous Cell Carcinoma;   Nasopharyngeal Carcinoma;   Head and Neck Squamous Cell Carcinoma
Interventions: Biological: 3 mg/kg humanized anti-PD-1 mAb;   Biological: 10 mg/kg humanized anti-PD-1 mAb
5 Recruiting Evaluation of De-escalated Adjuvant Radiation Therapy for Human Papillomavirus (HPV)-Associated Oropharynx Cancer
Condition: Oropharynx Cancer
Interventions: Radiation: Adjuvant Radiation Therapy;   Drug: Docetaxel;   Drug: Cisplatin
6 Not yet recruiting Endostar Combined With Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Endostar;   Drug: DDP
7 Recruiting A Trial of Endostar in Patients With Carcinoma of the Head and Neck
Condition: Nasopharyngeal Neoplasms
Intervention: Drug: Endostar
8 Recruiting A Phase II Trial of S-1 as Maintenance Treatment After Gemcitabine Plus Cisplatin Regimen Chemotherapy in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma.
Condition: Nasopharyngeal Carcinoma.
Intervention: Drug: S-1
9 Not yet recruiting Avelumab for Recurrent/Metastatic Nasopharyngeal Cancer
Condition: Nasopharyngeal Cancer
Intervention: Drug: Avelumab
10 Not yet recruiting ADjuVant Apatinib in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy
Condition: Nasopharyngeal Neoplasms
Interventions: Drug: Apatinib;   Drug: Placebo
11 Not yet recruiting Incidence of Dysphagia in Intensive Care Patients With Tracheostomy
Conditions: Dysphagia;   Oropharyngeal Dysphagia
Intervention: Device: high resolution impedance manometry with Automated Impedance Manometry analysis
12 Not yet recruiting Two Cycles Versus Three Cyclle of CCRT for Low Risk Locoregionally Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention: Drug: Cisplatin combine with IMRT
13 Recruiting Improving the Diagnosis of Tonsillitis in Emergency Rooms
Condition: Tonsillitis
Intervention: Other: Nasopharyngeal swab
14 Recruiting E7 TCR T Cells With or Without PD-1 Blockade for Human Papillomavirus-Associated Cancers
Conditions: Cervical Cancer;   Vaginal Cancer;   Anal Cancer;   Penile Cancer;   Oropharyngeal Cancer
Interventions: Biological: E7 TCR cells;   Drug: pembrolizumab;   Drug: aldesleukin;   Drug: fludarabine;   Drug: cyclophosphamide
15 Not yet recruiting Dietary Nitrate on Salivary Flow for Nasopharyngeal Carcinoma Patients
Condition: Nasopharyngeal Carcinoma
Interventions: Dietary Supplement: Sodium nitrate;   Dietary Supplement: sodium chloride
16 Recruiting Combination of Cryosurgey and NK Immunotherapy for Recurrent Pharyngeal Cancer
Condition: Recurrent Pharyngeal Cancer
Interventions: Device: Cryosurgery;   Biological: NK immunotherapy
17 Recruiting Incidence and Severity of Postoperative Sore Throat And Intubation Response by Using Different Devices for Endotracheal Intubation
Conditions: Pharyngitis;   Endotracheal Intubation;   Pain
Intervention: Device: Endotracheal intubation
18 Not yet recruiting Influence of 0.75% Ropivacaine Topicalization on Emergence Agitation in Children
Condition: Tonsillitis
Interventions: Drug: normal saline;   Drug: ropivacaine
19 Not yet recruiting Validation of the French Version of the Sydney Swallow Questionnaire in Patients With Neuromuscular Diseases
Conditions: Dysphagia;   Neuromuscular Diseases
Intervention: Other: Sydney Swallow Questionnaire
20 Not yet recruiting Autologous Muscle Derived Cells for Gastro-Intestinal Repair (AMDC-GIR) for Tongue Dysphagia
Condition: Oropharyngeal Dysphagia
Intervention: Drug: Autologous Muscle Derived Cells for Gastro-Intestinal Repair (AMDC-GIR)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years